Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing – Magnetic imaging agent
Patent
1998-11-02
1999-11-09
Hollinden, Gary E.
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
Magnetic imaging agent
A61B 5055
Patent
active
059808632
ABSTRACT:
An MRI contrast medium of improved safety and efficacy is disclosed. The composition includes a source of calcium ions and a source of manganese ions in a ratio of from 2:1 to 40:1 in a vehicle suitable for parenteral administration. A method of enhancing an MRI signal in a mammalian tissue with the foregoing composition is also provided.
REFERENCES:
patent: 4647447 (1987-03-01), Gries et al.
patent: 4719098 (1988-01-01), Weinmann et al.
patent: 4915933 (1990-04-01), Matwiyoff
patent: 4986980 (1991-01-01), Jacobsen
patent: 5078986 (1992-01-01), Bosworth et al.
patent: 5082649 (1992-01-01), Van Deripe
patent: 5250284 (1993-10-01), Krongrad
patent: 5401492 (1995-03-01), Kellar et al.
patent: 5458870 (1995-10-01), Deutsch et al.
patent: 5525326 (1996-06-01), Unger
patent: 5534240 (1996-07-01), Hasegawa et al.
patent: 5716598 (1998-02-01), Golman et al.
S. Schaeffer et al., "In Vivo Nuclear Magnetic Resonance Imaging of Myocardial Perfusion Using the Paramagnetic Contrast Agent Manganese Gluconate," JACC 14(2), pp. 472-480 (1989).
S. Schaeffer et al., "Nuclear Magnetic Resonance Imaging of Partial Coronary Artery Occlusion" (Abstract), Soc Magn Res in Med, p. 329 (1987).
S. Schaeffer et al., "Assessment of myocardial perfusion in vivo using nuclear magnetic resonance imaging" (Abstract), Magn Reson Imag, p. 133 (1987).
S. Schaeffer et al., "Contrast-Enhanced Magnetic Resonance Imaging of Hypoperfused Myocardium," Investigative Radiology 26, pp. 551-556 (1991).
M. Spiller et al., "Longitudinal Proton Relaxation Rates in a Rabbit Tissues after Intravenous Injection of Free and Chelated Mn.sup.2+," Mag Reson in Med 8, 293-313 (1988).
M.E. Bernadino et al., "Safety and Optimum Concentration of a maganese Chloride-based Oral MR Contrast Agent, " JMRI 4(6), pp. 872-876 (1994).
Harnish Phillip P.
Seoane Peter R.
Vessey Adele R.
Eagle Vision Pharmaceutical Corporation
Hollinden Gary E.
LandOfFree
Manganese compositions and methods for MRI does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Manganese compositions and methods for MRI, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Manganese compositions and methods for MRI will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1451663